Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIO-11006 in COPD
NCT00648245Phase 2Completed
- Sponsor
- BioMarck Pharmaceuticals, Ltd.
- Start
- Jun 2008
- Primary completion
- Jul 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BIO-11006 in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), sponsored by BioMarck Pharmaceuticals, Ltd.. Started Jun 2008; status: completed.
02
Drugs
BIO-11006
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00648245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00648245.